Search

Long D Pham

Examiner (ID: 4097, Phone: (571)270-5573 , Office: P/2691 )

Most Active Art Unit
2691
Art Unit(s)
2691, 2618, 2629
Total Applications
886
Issued Applications
640
Pending Applications
43
Abandoned Applications
203

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17472525 [patent_doc_number] => 20220080029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-17 [patent_title] => COMPOSITION COMPRISING SERICIN FOR TREATING, PREVENTING, OR ALLEVIATING FATTY LIVER, AND METHOD OF PREPARING SAME [patent_app_type] => utility [patent_app_number] => 17/420130 [patent_app_country] => US [patent_app_date] => 2019-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3210 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17420130 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/420130
COMPOSITION COMPRISING SERICIN FOR TREATING, PREVENTING, OR ALLEVIATING FATTY LIVER, AND METHOD OF PREPARING SAME Dec 22, 2019 Abandoned
Array ( [id] => 16749923 [patent_doc_number] => 20210101932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-08 [patent_title] => BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR PD-L1 [patent_app_type] => utility [patent_app_number] => 17/044868 [patent_app_country] => US [patent_app_date] => 2019-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13303 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044868 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/044868
BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR PD-L1 Dec 22, 2019 Pending
Array ( [id] => 15895339 [patent_doc_number] => 20200147188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-14 [patent_title] => THERAPEUTIC COMPOSITION CONTAINING ANTITHROMBIN GAMMA [patent_app_type] => utility [patent_app_number] => 16/709499 [patent_app_country] => US [patent_app_date] => 2019-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7897 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16709499 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/709499
THERAPEUTIC COMPOSITION CONTAINING ANTITHROMBIN GAMMA Dec 9, 2019 Abandoned
Array ( [id] => 17383946 [patent_doc_number] => 20220031798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => METHODS AND COMPOSITIONS FOR THE TREATMENT OF OPIOID DEPENDENCE AND FOR THE TREATMENT OF PAIN [patent_app_type] => utility [patent_app_number] => 17/298664 [patent_app_country] => US [patent_app_date] => 2019-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5912 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17298664 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/298664
METHODS AND COMPOSITIONS FOR THE TREATMENT OF OPIOID DEPENDENCE AND FOR THE TREATMENT OF PAIN Dec 3, 2019 Pending
Array ( [id] => 15934207 [patent_doc_number] => 20200158737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-21 [patent_title] => METHODS OF MEASURING UBIQUITIN-LIKE MODIFICATIONS [patent_app_type] => utility [patent_app_number] => 16/688235 [patent_app_country] => US [patent_app_date] => 2019-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14612 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16688235 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/688235
METHODS OF MEASURING UBIQUITIN-LIKE MODIFICATIONS Nov 18, 2019 Pending
Array ( [id] => 15556793 [patent_doc_number] => 20200062808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-27 [patent_title] => PEPTIDES AND COMPOSITIONS FOR PREVENTION OF CELL ADHESION AND METHODS OF USING SAME [patent_app_type] => utility [patent_app_number] => 16/680366 [patent_app_country] => US [patent_app_date] => 2019-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7100 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -39 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16680366 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/680366
Peptides and compositions for prevention of cell adhesion and methods of using same Nov 10, 2019 Issued
Array ( [id] => 17602902 [patent_doc_number] => 11331371 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-17 [patent_title] => Labyrinthopeptins as anti-viral agents [patent_app_type] => utility [patent_app_number] => 16/665956 [patent_app_country] => US [patent_app_date] => 2019-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 21 [patent_no_of_words] => 21053 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16665956 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/665956
Labyrinthopeptins as anti-viral agents Oct 27, 2019 Issued
Array ( [id] => 17343965 [patent_doc_number] => 20220010296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-13 [patent_title] => METHODS AND COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/288798 [patent_app_country] => US [patent_app_date] => 2019-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33805 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17288798 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/288798
METHODS AND COMPOSITIONS Oct 23, 2019 Pending
Array ( [id] => 16421908 [patent_doc_number] => 20200347106 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-05 [patent_title] => COMPOSITIONS AND METHODS OF USING ISLET NEOGENESIS PEPTIDES AND ANALOGS THEREOF [patent_app_type] => utility [patent_app_number] => 16/658218 [patent_app_country] => US [patent_app_date] => 2019-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22890 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16658218 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/658218
COMPOSITIONS AND METHODS OF USING ISLET NEOGENESIS PEPTIDES AND ANALOGS THEREOF Oct 20, 2019 Abandoned
Array ( [id] => 15496235 [patent_doc_number] => 20200048306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-13 [patent_title] => PRODRUG OF AN ICE INHIBITOR [patent_app_type] => utility [patent_app_number] => 16/657191 [patent_app_country] => US [patent_app_date] => 2019-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7158 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16657191 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/657191
PRODRUG OF AN ICE INHIBITOR Oct 17, 2019 Abandoned
Array ( [id] => 17258476 [patent_doc_number] => 20210371461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-02 [patent_title] => Novel chemiluminescent substrates for Factor Xa [patent_app_type] => utility [patent_app_number] => 17/285098 [patent_app_country] => US [patent_app_date] => 2019-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15086 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17285098 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/285098
Novel chemiluminescent substrates for Factor Xa Oct 16, 2019 Pending
Array ( [id] => 16153859 [patent_doc_number] => 20200215162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-09 [patent_title] => Methods for Producing Stable Therapeutic Formulations in Aprotic Polar Solvents [patent_app_type] => utility [patent_app_number] => 16/600722 [patent_app_country] => US [patent_app_date] => 2019-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15389 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16600722 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/600722
Methods for Producing Stable Therapeutic Formulations in Aprotic Polar Solvents Oct 13, 2019 Abandoned
Array ( [id] => 18800123 [patent_doc_number] => 11833269 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-12-05 [patent_title] => Hyaluronic acid-collagen matrices for dermal filling and volumizing applications [patent_app_type] => utility [patent_app_number] => 16/595481 [patent_app_country] => US [patent_app_date] => 2019-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 7953 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16595481 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/595481
Hyaluronic acid-collagen matrices for dermal filling and volumizing applications Oct 7, 2019 Issued
Array ( [id] => 17214502 [patent_doc_number] => 20210347839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-11 [patent_title] => Disease Treatment Drug Based on Mesenchymal-Stem-Cell Mobilization [patent_app_type] => utility [patent_app_number] => 17/282872 [patent_app_country] => US [patent_app_date] => 2019-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13378 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17282872 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/282872
Disease Treatment Drug Based on Mesenchymal-Stem-Cell Mobilization Oct 3, 2019 Pending
Array ( [id] => 15405431 [patent_doc_number] => 20200023037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-23 [patent_title] => PTD-SMAD7 THERAPEUTICS [patent_app_type] => utility [patent_app_number] => 16/584608 [patent_app_country] => US [patent_app_date] => 2019-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38267 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16584608 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/584608
PTD-SMAD7 THERAPEUTICS Sep 25, 2019 Abandoned
Array ( [id] => 17200227 [patent_doc_number] => 20210340322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-04 [patent_title] => AMPHIPHILIC POLY (AMINO ACID), BLOCK COPOLYER USING THE AMPHIPHILIC POLY (AMINO ACID), AND COMPLEX INCLUDING THE AMPHIPHILIC POLY (AMINO ACID) OR THE BLOCK COPOLYMER AND NUCLEIC ACID [patent_app_type] => utility [patent_app_number] => 17/280058 [patent_app_country] => US [patent_app_date] => 2019-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10229 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 243 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17280058 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/280058
AMPHIPHILIC POLY (AMINO ACID), BLOCK COPOLYER USING THE AMPHIPHILIC POLY (AMINO ACID), AND COMPLEX INCLUDING THE AMPHIPHILIC POLY (AMINO ACID) OR THE BLOCK COPOLYMER AND NUCLEIC ACID Sep 24, 2019 Pending
Array ( [id] => 17952453 [patent_doc_number] => 11478527 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-25 [patent_title] => FGF receptor ligands for treating diabetes and obesity [patent_app_type] => utility [patent_app_number] => 16/574151 [patent_app_country] => US [patent_app_date] => 2019-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5346 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 170 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16574151 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/574151
FGF receptor ligands for treating diabetes and obesity Sep 17, 2019 Issued
Array ( [id] => 17052169 [patent_doc_number] => 20210261603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-26 [patent_title] => SITE-SPECIFIC SERINE ADP-RIBOSYLATED PROTEINS AND PEPTIDES AND METHOD FOR PRODUCING THE SAME [patent_app_type] => utility [patent_app_number] => 17/276772 [patent_app_country] => US [patent_app_date] => 2019-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15604 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17276772 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/276772
SITE-SPECIFIC SERINE ADP-RIBOSYLATED PROTEINS AND PEPTIDES AND METHOD FOR PRODUCING THE SAME Sep 16, 2019 Pending
Array ( [id] => 17420028 [patent_doc_number] => 11253456 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-02-22 [patent_title] => Anti-inflammatory peptides, and uses thereof [patent_app_type] => utility [patent_app_number] => 16/569159 [patent_app_country] => US [patent_app_date] => 2019-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 33 [patent_no_of_words] => 21981 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16569159 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/569159
Anti-inflammatory peptides, and uses thereof Sep 11, 2019 Issued
Array ( [id] => 17183851 [patent_doc_number] => 20210330736 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-28 [patent_title] => USE OF A PDE11 OR PDE2 INHIBITOR FOR THE TREATMENT OF PARKINSON'S DISEASE [patent_app_type] => utility [patent_app_number] => 17/271978 [patent_app_country] => US [patent_app_date] => 2019-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14047 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17271978 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/271978
USE OF A PDE11 OR PDE2 INHIBITOR FOR THE TREATMENT OF PARKINSON'S DISEASE Sep 4, 2019 Pending
Menu